肝硬化增加带状疱疹风险:一项全国性人群队列研究
该研究利用韩国2009至2019年健康保险审查评价院理赔数据库,纳入504,986例肝硬化患者,分析带状疱疹发病率与标准化发病比。肝硬化患者带状疱疹及带状疱疹相关住院的标准化发病比分别为1.09(95%CI:1.08-1.09)和1.48(95%CI:1.44-1.52),均显著高于普通人群。女性、使用类固醇、使用免疫抑制剂及合并症与肝硬化患者带状疱疹风险升高相关。
要点
- 肝硬化患者带状疱疹标准化发病比为1.09(95%CI:1.08-1.09),显著高于普通人群。
- 肝硬化患者带状疱疹相关住院标准化发病比为1.48(95%CI:1.44-1.52)。
- 女性、类固醇使用、免疫抑制剂使用及合并症与肝硬化患者带状疱疹风险升高相关。
核心结论
- 肝硬化患者,尤其是当前未被推荐接种带状疱疹疫苗者,其带状疱疹及带状疱疹相关住院风险高于韩国普通人群。
研究设计与样本
- 基于韩国健康保险审查评价院2009至2019年理赔数据库的全国性人群队列研究,共纳入504,986例韩国肝硬化患者。
- 带状疱疹定义为存在国际疾病分类第10版带状疱疹编码并同时处方抗病毒药物。
- 分析肝硬化患者带状疱疹的发病率与标准化发病比。
主要发现
- 纳入的504,986例肝硬化患者平均年龄52.4岁,60.8%为男性,慢性乙型肝炎是最常见病因。
- 带状疱疹发病率为21.6/1000人年,带状疱疹相关住院率为1.81/1000人年。
- 带状疱疹标准化发病比为1.09(95%CI:1.08-1.09),带状疱疹相关住院标准化发病比为1.48(95%CI:1.44-1.52),均显著高于普通人群。
- 20-29岁、30-39岁、40-49岁肝硬化患者带状疱疹标准化发病比分别为1.41(95%CI:1.33-1.48)、1.16(95%CI:1.13-1.19)、1.17(95%CI:1.13-1.19)。
- 多因素分析中,女性(调整风险比[AHR]:1.48)、类固醇使用(AHR:1.20)、免疫抑制剂使用(AHR:1.26)及合并症与肝硬化患者带状疱疹风险升高相关。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Limited data are available regarding the association between liver cirrhosis (LC) and the risk of herpes zoster (HZ). This study aimed to determine the risk of HZ in patients with LC. METHODS: HZ was defined as the presence of the International Classification of Diseases-10th revision code for HZ and concomitant prescription of antiviral medication. The incidence rates and standardized incidence ratios (SIRs) of HZ in patients with LC were analyzed using data from the Health Insurance Review and Assessment Service in Korea claims database from 2009 to 2019. RESULTS: A total of 504,986 Korean patients with LC were included. The mean age was 52.4 years, and 60.8% were men. Chronic hepatitis B was the most common cause of LC. The incidence rates for HZ and HZ-related hospitalization were 21.6 of 1,000 and 1.81 of 1,000 person-years, respectively. The SIRs for HZ and HZ-related hospitalization were 1.09 (95% confidence interval [CI]: 1.08-1.09) and 1.48 (95% CI: 1.44-1.52), respectively, which were significantly higher than those in the general population. Patients with LC aged 20-29, 30-39, and 40-49 years had SIRs for HZ of 1.41 (95% CI: 1.33-1.48), 1.16 (1.13-1.19), and 1.17 (1.13-1.19), respectively. In multivariable analysis, woman (adjusted hazard ratio [AHR]: 1.48), steroid (AHR: 1.20), immunosuppressant use (AHR: 1.26), and combined comorbidities were associated with an increased risk of HZ among patients with LC. DISCUSSION: Patients with LC, particularly those who are not currently recommended for HZ vaccination, were at an increased risk of HZ and HZ-related hospitalization compared with the general Korean population.
引用
- Jeon D, Kim YJ, Kim S, et al. Liver Cirrhosis Increases the Risk of Herpes Zoster: A Nationwide Population-Based Cohort Study. Am J Gastroenterol. 2023. PMID: 36746415. doi:10.14309/ajg.0000000000002209
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。